Document Type
Article
Publication Date
7-5-2025
Identifier
DOI: 10.1038/s41398-025-03460-x; PMCID: PMC12228681
Abstract
Treatments for generalized anxiety disorder (GAD) often aim to address maladaptive approach-avoidance behavior patterns. Approach-avoidance conflict (AAC) offers a potential framework for identifying treatment outcome predictors and informing optimization of GAD treatment. The current study examined whether pre-treatment neurobehavioral AAC indices predict symptom improvement in behavioral activation (BA) and exposure therapy (EXP) for GAD. Treatment-seeking adults meeting criteria for GAD completed a randomized clinical trial with pre-treatment blinding, conducted from 2016-2021. Participants were randomized to complete 10 manualized sessions of BA or EXP. Participants completed an AAC task during functional magnetic resonance imaging pre-treatment. Computational parameters of task behavior were derived, and neural activity was assessed during decision-making and positive and negative outcomes of decisions. Outcome measures were GAD symptoms and depressive symptoms. Of 121 participants recruited, 56 (29 BA, 27 EXP; mean age 33.0 years; 12.5% male) treatment completers were included in analyses. Greater AAC task avoidance (d = -0.28) and greater left dorsolateral prefrontal cortex activation during negative outcomes (d = -0.32), predicted greater symptom reduction across treatments. Blunted left amygdala activation to positive outcomes was associated at a trend level with favorable symptom reduction for BA but not EXP (d = -0.20). The dorsolateral prefrontal cortex may be a target for enhancing behavior therapy outcomes generally, while left amygdala activation to positive affect may be a target for enhancing outcomes for BA. These findings may inform the optimization of behavioral therapies for GAD and hold potential for transdiagnostic applications, warranting larger, longitudinal studies in clinical settings. Clinical Trials Registration: ClinicalTrials.gov NCT02807480.
Journal Title
Transl Psychiatry
Volume
15
Issue
1
First Page
231
Last Page
231
MeSH Keywords
Humans; Male; Female; Adult; Anxiety Disorders; Magnetic Resonance Imaging; Implosive Therapy; Treatment Outcome; Conflict, Psychological; Avoidance Learning; Young Adult; Dorsolateral Prefrontal Cortex; Middle Aged; Generalized Anxiety Disorder
PubMed ID
40617801
Keywords
Anxiety Disorders; Magnetic Resonance Imaging; Implosive Therapy; Treatment Outcome; Psychological Conflict; Avoidance Learning; Dorsolateral Prefrontal Cortex; Generalized Anxiety Disorder
Recommended Citation
Berg H, McDermott TJ, Kuplicki R, et al. Prediction of generalized anxiety disorder treatment outcomes with neurobehavioral responses to approach-avoidance conflict: a randomized clinical trial. Transl Psychiatry. 2025;15(1):231. Published 2025 Jul 5. doi:10.1038/s41398-025-03460-x
Comments
Grants and funding
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Publisher's Link: https://www.nature.com/articles/s41398-025-03460-x